申请人:LTS Lohmann Therapie-Systeme AG
公开号:US10881607B2
公开(公告)日:2021-01-05
The invention relates to a composition for transdermal delivery, particularly iontophoretic transdermal delivery, of at least one cationic active agent or a salt thereof. The composition includes at least one cationic active agent or a salt thereof, at least one polyamine or/and polyamine salt, water or an aqueous solvent mixture, and optionally one or more additives. The invention further relates to the use of such composition as a component of a transdermal patch or of an iontophoretic transdermal patch, as well as to the use of such composition in a method for transdermally and/or iontophoretically administering cationic active agents. The invention further includes methods for determining the in vitro skin permeation properties of an active-agent-containing iontophoretic composition.
本发明涉及至少一种阳离子活性剂或其盐的透皮给药组合物,特别是离子透皮给药组合物。该组合物包括至少一种阳离子活性剂或其盐、至少一种多胺或/和多胺盐、水或水性溶剂混合物,以及可选的一种或多种添加剂。本发明还涉及将这种组合物用作透皮贴剂或离子透皮贴剂的成分,以及将这种组合物用于阳离子活性剂的透皮和/或离子透皮给药方法。本发明还包括确定含活性剂的离子透皮组合物的体外皮肤渗透特性的方法。